Common Contracts
10 similar Incentive Stock Option Agreement contracts by Acacia Communications, Inc., Editas Medicine, Inc., Syros Pharmaceuticals, Inc., others
ARSANIS, INC. INCENTIVE STOCK OPTION AGREEMENTIncentive Stock Option Agreement • October 20th, 2017 • Arsanis, Inc. • Biological products, (no disgnostic substances)
This option satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities.
KALA PHARMACEUTICALS, INC. INCENTIVE STOCK OPTION AGREEMENTIncentive Stock Option Agreement • July 10th, 2017 • Kala Pharmaceuticals, Inc. • Pharmaceutical preparations
This option satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities.
VISTERRA, INC. INCENTIVE STOCK OPTION AGREEMENTIncentive Stock Option Agreement • January 17th, 2017 • Visterra, Inc. • Pharmaceutical preparations
This option satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities.
SYROS PHARMACEUTICALS, INC. INCENTIVE STOCK OPTION AGREEMENTIncentive Stock Option Agreement • June 3rd, 2016 • Syros Pharmaceuticals, Inc. • Pharmaceutical preparations
This option satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities.
VIAMET PHARMACEUTICALS CORP. INCENTIVE STOCK OPTION AGREEMENTIncentive Stock Option Agreement • April 8th, 2016 • Viamet Pharmaceuticals Holdings LLC • Pharmaceutical preparations
This option satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities.
ACACIA COMMUNICATIONS, INC. INCENTIVE STOCK OPTION AGREEMENTIncentive Stock Option Agreement • February 24th, 2016 • Acacia Communications, Inc. • Semiconductors & related devices
This option satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities.
SYROS PHARMACEUTICALS, INC. INCENTIVE STOCK OPTION AGREEMENTIncentive Stock Option Agreement • February 5th, 2016 • Syros Pharmaceuticals, Inc. • Pharmaceutical preparations
This option satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities.
EDITAS MEDICINE, INC. INCENTIVE STOCK OPTION AGREEMENTIncentive Stock Option Agreement • January 4th, 2016 • Editas Medicine, Inc. • Biological products, (no disgnostic substances)
This option satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities.
EDITAS MEDICINE, INC. INCENTIVE STOCK OPTION AGREEMENTIncentive Stock Option Agreement • December 15th, 2015 • Editas Medicine, Inc. • Biological products, (no disgnostic substances)
This option satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities.
ACACIA COMMUNICATIONS, INC. INCENTIVE STOCK OPTION AGREEMENTIncentive Stock Option Agreement • November 18th, 2015 • Acacia Communications, Inc. • Semiconductors & related devices
This option satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities.
